Troendle August J.
Troendle August J., PRES, CEO, reported an open-market or private sale at Medpace Holdings, Inc. involving 27174.000000 shares for an estimated $16814999.46. Reported holdings after the transaction were 561195.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 20, 2026
- Filing date
- Aug 21, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 588,369 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
MEDP price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0000892251-26-000125 Common Stock
- Transaction date
- Aug 20, 2026 Filed Aug 21, 2026, 08:13 PM · 1d delay
- Shares
- 27,174 sh $618.79 per share
- Estimated value
- -$16.8M Computed from shares × price
- Holdings after
- 561,195 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
President & CEO
- F1
The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
- F2
The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $601.29 to $611.42. The Reporting Person undertakes to provide full pricing information to…
- F3
The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $606.20 to $626.51. The Reporting Person undertakes to provide full pricing information to…
- F4
The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Report…
0 other transactions
0 recent txs